← Back to headlines
Vertex Tops Profit Estimates as New Cystic Fibrosis Drug Sales Surge
Vertex Pharmaceuticals exceeded profit estimates, driven by a significant surge in sales of its new cystic fibrosis drug. The strong performance highlights the drug's market success.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
